X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (41) 41
humans (37) 37
male (28) 28
adult (27) 27
female (25) 25
substance abuse (23) 23
buprenorphine (20) 20
psychiatry (20) 20
middle aged (17) 17
dependency (16) 16
usa (16) 16
buprenorphine - administration & dosage (13) 13
drug abuse (13) 13
drug use (12) 12
methadone (12) 12
substance abuse treatment (12) 12
buprenorphine - therapeutic use (11) 11
opioid-related disorders - rehabilitation (11) 11
opioid dependence (10) 10
pharmacotherapy (10) 10
treatment outcome (10) 10
care and treatment (9) 9
heroin (9) 9
naloxone (9) 9
opioid-related disorders - psychology (9) 9
psychology, clinical (9) 9
double-blind method (8) 8
medicine, research & experimental (8) 8
narcotic antagonists - administration & dosage (8) 8
administration, sublingual (7) 7
amyloidosis (7) 7
article (7) 7
clinical trials (7) 7
detoxification (7) 7
drug administration schedule (7) 7
narcotic antagonists - therapeutic use (7) 7
opioids (7) 7
transthyretin (7) 7
treatment outcomes (7) 7
analysis of variance (6) 6
naloxone - therapeutic use (6) 6
neurosciences (6) 6
pharmacology & pharmacy (6) 6
research (6) 6
treatment (6) 6
usage (6) 6
withdrawal (6) 6
abuse (5) 5
addiction (5) 5
biochemistry & molecular biology (5) 5
clinical-trial (5) 5
dose-response relationship, drug (5) 5
drug combinations (5) 5
health aspects (5) 5
heroin dependence (5) 5
medicine, general & internal (5) 5
polyneuropathies (5) 5
psychiatric status rating scales (5) 5
substance withdrawal syndrome - drug therapy (5) 5
val30met (5) 5
addiction severity index (4) 4
adolescent (4) 4
aged (4) 4
buprenorphine - adverse effects (4) 4
cross-over studies (4) 4
diagnosis (4) 4
dosage (4) 4
drug therapy (4) 4
fap (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
hereditary amyloidosis (4) 4
heroin dependence - rehabilitation (4) 4
human (4) 4
maintenance (4) 4
men (4) 4
methadone-maintenance (4) 4
mutations (4) 4
naloxone - administration & dosage (4) 4
narcotic antagonists - adverse effects (4) 4
neuropathy (4) 4
opioid-related disorders - drug therapy (4) 4
patient compliance (4) 4
pharmacology (4) 4
polyneuropathy (4) 4
psychological aspects (4) 4
reinforcement (4) 4
tafamidis (4) 4
abuse liability (3) 3
addicts (3) 3
alcohol (3) 3
amyloid neuropathies, familial - diagnosis (3) 3
analysis (3) 3
blockade (3) 3
buprenorphine-naloxone (3) 3
buprenorphine/naloxone (3) 3
clinical neurology (3) 3
clinical-trials network (3) 3
clonidine (3) 3
clonidine - therapeutic use (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Substance Abuse Treatment, ISSN 0740-5472, 2010, Volume 39, Issue 3, pp. 255 - 263
Journal Article
Addiction, ISSN 0965-2140, 04/2010, Volume 105, Issue 4, pp. 709 - 718
Journal Article
Amyloid, ISSN 1350-6129, 01/2017, Volume 24, Issue 1, pp. 30 - 36
Background: Tafamidis, a non-NSAID highly specific transthyretin stabilizer, delayed neurologic disease progression as measured by Neuropathy Impairment... 
familial amyloid neuropathy | Amyloidosis | disease-modifying drug | tafamidis | transthyretin | polyneuropathy | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | HEREDITARY AMYLOIDOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUTATIONS | TRANSPLANTATION | Index Medicus
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 03/2016, Volume 21, Issue 1, pp. 5 - 9
Transthyretin familial amyloid polyneuropathy ( TTR‐FAP ) is a rare, progressive, life‐threatening, hereditary disorder caused by mutations in the... 
diagnosis | hereditary amyloidosis | transthyretin familial amyloid neuropathy | transthyretin | Review
Journal Article
Muscle & Nerve, ISSN 0148-639X, 05/2018, Volume 57, Issue 5, pp. 829 - 837
Journal Article
Muscle & Nerve, ISSN 0148-639X, 09/2016, Volume 54, Issue 3, pp. 353 - 360
Journal Article
Journal of Substance Abuse Treatment, ISSN 0740-5472, 2008, Volume 34, Issue 2, pp. 208 - 214
Abstract This study examined how having a history of sexual, physical, or emotional abuse is related to overall functioning as assessed by the Addiction... 
Psychiatry | Latent growth model | Buprenorphine/naloxone | Opioid treatment | Adult | Sexual abuse | Addiction Severity Index | Physical abuse | Methadone | Emotional abuse | CHILDHOOD MALTREATMENT | emotional abuse | physical abuse | opioid treatment | VICTIMIZATION | latent growth model | SUBSTANCE ABUSE | PREVALENCE | PSYCHOLOGY, CLINICAL | sexual abuse | WOMEN | GENERAL-POPULATION | MEN | addiction severity index | LINK | MEDIATORS | OUTCOMES | adult | methadone | buprenorphine/naloxone | Severity of Illness Index | Double-Blind Method | Heroin Dependence - drug therapy | Humans | Middle Aged | Methadone - therapeutic use | Analgesics, Opioid - therapeutic use | Male | Naloxone - therapeutic use | Treatment Outcome | Domestic Violence - psychology | Heroin Dependence - psychology | Psychiatric Status Rating Scales | Buprenorphine - therapeutic use | Narcotic Antagonists - therapeutic use | Time Factors | Adolescent | Sex Factors | Female | Aged | Heroin Dependence - rehabilitation | Sex Offenses - psychology | Social Adjustment | Psychological aspects | Influence | Methadone maintenance | Adult child sexual abuse victims | Methadone hydrochloride | Care and treatment | Buprenorphine | Analysis | Substance abuse | Domestic relations | Studies | Sex crimes | Substance abuse treatment | Clinical trials | Alcohol use | Index Medicus
Journal Article
Amyloid, ISSN 1350-6129, 07/2017, Volume 24, Issue 3, pp. 194 - 204
Background: The objective of the present study was to evaluate the long-term safety and efficacy of tafamidis in treating hereditary transthyretin amyloid... 
ATTRV30M | Amyloidosis | disease-modifying drug | non-ATTRV30M | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | STABILIZATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | VAL30MET | TRANSPLANTATION | TRIAL | MEDICINE, GENERAL & INTERNAL | FAP | MUTATIONS | OUTCOMES | REGISTRY | Index Medicus
Journal Article
Addiction, ISSN 0965-2140, 01/2012, Volume 107, Issue 1, pp. 142 - 151
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2015, Volume 10, Issue Suppl 1, p. P12
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 03/2016, Volume 21, Issue 1, pp. 5 - 9
Journal Article
Journal of Substance Abuse Treatment, ISSN 0740-5472, 2007, Volume 32, Issue 2, pp. 167 - 175
Abstract For opioid-dependent patients, the need for detoxification has been a barrier to entry into long-term residential treatment. This report describes a... 
Psychiatry | Opioid dependence | Residential treatment | Buprenorphine | Therapeutic community | Treatment retention | DETOXIFICATION | NALOXONE TABLET | DATOS | residential treatment | RANDOMIZED-TRIAL | SUBSTANCE ABUSE | PSYCHOLOGY, CLINICAL | therapeutic community | CLINICAL-TRIALS NETWORK | treatment retention | DRUG-ABUSE | buprenorphine | FOLLOW-UP OUTCOMES | METHADONE | HEROIN WITHDRAWAL | opioid dependence | Patient Dropouts - psychology | Humans | Middle Aged | Male | Narcotics - therapeutic use | Long-Term Care | Heroin Dependence - psychology | Cocaine-Related Disorders - rehabilitation | New York City | Opioid-Related Disorders - rehabilitation | Residential Treatment | Adult | Female | Heroin Dependence - rehabilitation | Retrospective Studies | Therapeutic Community | Alcoholism - psychology | Opioid-Related Disorders - psychology | Cocaine-Related Disorders - psychology | Naloxone - therapeutic use | Clinical Trials as Topic | Substance Withdrawal Syndrome - rehabilitation | Alcoholism - rehabilitation | Buprenorphine - therapeutic use | Narcotic Antagonists - therapeutic use | Neurologic Examination - drug effects | Substance Withdrawal Syndrome - psychology | Drug abuse | Care and treatment | Dosage and administration | Research | Health aspects | Drugs | Substance abuse treatment | Drug therapy | Index Medicus
Journal Article